Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2021-07-05 Regulatory Filings
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' It details a 'Price Monitoring Extension' which is a specific operational announcement related to trading on the London Stock Exchange. Since this is a general regulatory announcement that doesn't fit into the specific categories like 10-K, ER, or DIV, and it is clearly branded as an RNS communication, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2023 chars), but it is the primary content itself, not an announcement *about* another report.
2021-07-05 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (2007 characters) and contains the header 'RNS Number : 9202D'. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific market operation announcement. Since it is a short, specific regulatory update that doesn't fit into the major financial reporting categories (like 10-K, IR, ER), and it is distributed via RNS (the news service of the London Stock Exchange), it best fits the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements not covered by more specific codes. It is not an announcement of a major report (RPA), nor is it about dividends, management changes, or capital structure.
2021-07-01 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. It details a 'Price Monitoring Extension' which is a specific operational announcement related to trading mechanisms on the exchange. Since this is a general regulatory announcement from the London Stock Exchange's news service (RNS) that does not fit into the specific categories like ER, 10-K, or DIV, the most appropriate classification is the general regulatory announcement category, RNS.
2021-07-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number (4894Q) and the header 'RNS Number : 4894Q' and the closing statement 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory announcement disseminated via the London Stock Exchange's RNS system. The content specifically announces the 'Total Voting Rights' as of a specific date (26 February 2021), stating the total number of ordinary shares and voting rights. This type of mandatory disclosure regarding share capital structure and voting rights is a standard regulatory filing. Since there is no specific category for 'Total Voting Rights' announcement, and it is a general regulatory announcement provided via RNS, the most appropriate classification is the general regulatory filing category, RNS, unless it fits a more specific category. It is not an ER, IR, 10-K, or a notice of a meeting/vote result (DVA). Therefore, RNS is the best fit.
2021-02-26 English
Director / PDMR notification
Director's Dealing Classification · 100% confidence The document is identified by the header 'RNS Number : 6572P' and concludes with standard RNS disclaimers, indicating it is a regulatory announcement distributed via the London Stock Exchange's news service. The content details a 'Director / PDMR notification' where the Non-executive Chairman subscribed for new shares, and subsequent admission to trading is announced. This specifically relates to personal share transactions by a director (insider trading/dealing). This aligns perfectly with the definition for Director's Dealing (DIRS). Although it is an RNS filing, DIRS is the more specific category.
2021-02-19 English
Placing of new ordinary shares to raise £50,000
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces a 'Placing of new ordinary shares to raise £50,000,' which is a corporate action related to fundraising and capital structure. This directly aligns with the definition of a Capital/Financing Update (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP the most specific classification. It is not a general regulatory announcement (RNS) because the subject is highly specific (fundraising via placing). The document length is substantial enough (9821 chars) that it is not merely an announcement of a report (RPA).
2021-02-19 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.